BMRA vs IDXX · rev $4.5M vs P/E 40, rev $2.36B
Biomerica Inc (BMRA) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Biomerica Inc (BMRA) is a medical devices company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
BMRA currently screens at market cap $8.0M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the BMRA and IDXX stock pages for the full models.
Not investment advice.